Clinical Trial Update: Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring non-damaging retinal laser therapy (PASCAL) for macular diseases; status and results not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Central Serous Retinopathy
• Diabetic Macular Edema
• Macular Telangiectasia

Drugs mentioned

• Non-damaging retinal laser therapy (PASCAL laser)

Snippet

Sponsor: Federal University of Rio Grande do Sul | Conditions: Diabetic Macular Edema, Branch Retinal Vein Occlusion | Phase 2 | Status: UNKNOWN